# InvestorNewsBreaks – Bioadaptives Inc (BDPT) Showcases Breakthrough Stem Cell Benefits in Regen Dog Chews

Bioadaptives (BDPT), through its premium pet wellness division PawPa(TM), announced compelling clinical results for its flagship product Regen(TM) Dog Chews, formulated to naturally stimulate stem cell release and support canine vitality, mobility, and comfort. In veterinarian-led trials, Regen demonstrated a 281.3% increase in circulating stem cells after four weeks. The product’s benefits are further measured using the company’s proprietary APBAR(R) rating system—modeled after the human APGAR score—helping pet owners track improvements in appearance, performance, behavior, attitude, and responsiveness. Crafted with all-natural ingredients including beneficial cyanobacteria and adaptogens, Regen(TM) is veterinarian-recommended, safe, and delivered in a tasty chew dogs love. With no reported adverse effects, Regen(TM) offers a daily, science-backed solution for pet wellness.

 To view the full press release, visit https://ibn.fm/gReBb

 About BioAdaptives, Inc.

 BioAdaptives, Inc. (OTC: BDPT) is a leading innovator in the health and wellness industry. We are dedicated to developing and marketing nutraceutical and wellness products that harness the power of natural ingredients and cutting-edge science. Our mission is to improve the quality of life for our customers by offering products that support optimal health and vitality.

 For more information, please visit our website at www.bioadaptives.com.

 About InvestorWire

 InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

 For more information, please visit https://www.InvestorWire.com

 Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

 InvestorWireAustin, Texaswww.InvestorWire.com512.354.7000 OfficeEditor@InvestorWire.com

 InvestorWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/iw/investornewsbreaks-bioadaptives-inc-bdpt-showcases-breakthrough-stem-cell-benefits-in-regen-dog-chews/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/bioadaptives-reveals-impressive-results-for-regen-tm-dog-chews-in-clinical-trials/500497413f1849106a8a7baeba6a58fe) 

 



[Reddit Post](https://www.reddit.com/r/Business_NewsRamp/comments/1kxlql2/bioadaptives_reveals_impressive_results_for/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/255/28/filejVEV.webp)